WASHINGTON (June 29, 2022)—Yesterday, the US Department of Health and Human Services launched a monkeypox vaccination campaign to combat rising cases of the viral illness. Critics note that many of the shortfalls that were seen during the early days of COVID could hamper the Monkeypox response.
The George Washington University has experts available to discuss the current state of monkeypox, vaccine roll out in the states, the need for better testing and other issues.
To interview an expert, please contact Kathy Fackelmann, [email protected], Lesley Swiger at [email protected] or GW Media at [email protected].
Lynn R. Goldman, MD, MS, MPH, the Michael and Lori Milken Dean of Milken Institute School of Public Health, is an expert on emergency/public health preparedness and has deep knowledge of the intersection of policy and public health. She can talk about prevention strategies including vaccines, distribution, access and ways to protect society’s most at-risk populations.
Jon Andrus, MD, an adjunct professor of global health, is an expert on vaccines, immunizations and response to emerging infectious disease threats. He previously served as the deputy director for the Pan American Health Organization, where he handled emergency response and preparedness. He can discuss safety and efficacy of the Monkeypox vaccines.
Christopher Mores, ScD, a professor of global health, is an arbovirologist and an expert on emerging infectious diseases. He can discuss virus transmission patterns and global health security strategies, including the use of vaccines, to counter threats.
Tara Palmore, MD, is a professor of medicine in the Division of Infectious Diseases at the George Washington University (GW) Medical Faculty Associates and GW School of Medicine and Health Sciences. She can speak about common signs and symptoms of the disease along with how physicians can best prepare for a rise in cases.
-GW-
-GW-